Developer docs
API playgroundTry for free, no card

Search company profiles

Sorcero

Full company profile

uuid00002jv

Namestring
Sorcero
Legal namestring
Sorcero, Inc.
Websiteurl
sorcero.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Sorcero, Inc. is a Washington, D.C.-based AI and data intelligence company founded in 2018 that builds a medically-tuned Agentic AI platform for the life sciences industry. The platform combines natural language processing with 1,000+ domain-specific biomedical ontologies to unify structured and unstructured data — including a Scientific Data Pool of 250M+ publications and 3.5M congress abstracts from 4,300+ global conferences — and produces traceable, evidence-grounded insights for medical affairs, scientific communications, pharmacovigilance, and medical device teams. The product is sold across three suites — Sorcero Medical™, Sorcero SciComms™, and Sorcero Safety™ — with adjunct solutions such as Field Medical Excellence & Insights, Congress Intelligence, Publication Intelligence, and the Therapy Resonance Profile.

The company operates an enterprise SaaS model sold primarily through direct high-touch field sales to global pharmaceutical companies, paired with dedicated Insights Leads, Deployment Strategists, and implementation services. Distribution channels include direct enterprise contracting (via procurement portals Ariba, Coupa, Jaggaer), the Google Cloud Marketplace, and the NIH Carahsoft STRIDES Initiative for public-sector buyers, with a native Sorcero Capture App on iPad/iPhone supporting field MSL workflows. Sorcero has raised $59M across a 2021 Series A and a 2025 Series B led by NewSpring Growth, acquired Axiom Health in 2025 to extend into medical devices, and reports penetration of approximately 40% of the top 30 global pharmaceutical companies. Certifications include SOC 2 Type II, ISO 27001, GDPR, DPF, and B Corporation status, with regulatory-grade performance benchmarks (99.83% sensitivity, 96.1% accuracy) supported by peer-reviewed validation studies in journals including JAMIA Open.

Short descriptiontext

Sorcero is a Washington, D.C.-based AI platform that delivers medically-tuned Agentic AI and data intelligence to global pharmaceutical, biotech, and medical device companies. It unifies 250M+ scientific publications and structured data into traceable insights for medical affairs, scientific communications, pharmacovigilance, and field medical workflows.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical affairs AI, pharmacovigilance software, literature monitoring automation, scientific content generation, biomedical intelligence platform
Industry4 codes
PRIMARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Software Publishers5132
Product category
Life Sciences AI Intelligence Platform
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Sorcero operates as a SaaS platform sold to enterprise life sciences organizations on a subscription basis, with enterprise contracts typically involving multi-year terms, dedicated implementation services, and platform licensing fees. The company pairs its platform with high-touch services including Insights Leads and Deployment Strategists to drive organizational alignment and adoption.

sorcero.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise SaaS platform with tiered product suites (Medical, SciComms, Safety)
ModelSubscriptionBilling cadenceAnnual
Notes

Enterprise pricing is custom/quote-based. No public pricing tiers listed on website. Multiple product suites (Sorcero Medical™, Sorcero SciComms™, Sorcero Safety™) are available as part of the platform. Contracts are typically multi-year enterprise agreements with implementation services included.

sorcero.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Sorcero Medical™
Description

Transforms fragmented data into unified, actionable intelligence for medical affairs teams, shifting scientific exchange from manual to strategic.

sorcero.com
+4 more records
Core offering1 text field

Sorcero builds and sells a medically-tuned Agentic AI platform for life sciences organizations that unifies structured and unstructured medical evidence from publications, congresses, CRM notes, and internal data into traceable, actionable insights. The platform is delivered through three product suites — Sorcero Medical™, Sorcero SciComms™, and Sorcero Safety™ — and is sold as an enterprise SaaS subscription with high-touch implementation services targeting global pharmaceutical, biotech, and medical device companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 12 values shown
  • 72% reduction in medical data analysis time
+11 more records
Product overview1 text field

Sorcero offers a unified AI intelligence platform for life sciences with three main product suites: Sorcero Medical™ (for medical affairs strategy and insights), Sorcero SciComms™ (for scientific content generation and publication intelligence), and Sorcero Safety™ (for pharmacovigilance and literature monitoring). The platform is powered by the Sorcero Intelligence Platform which unifies data from disparate sources and leverages medically-tuned Agentic AI. Key solutions include Medical Insights Management, Field Medical Excellence & Insights, Congress Intelligence, Publication Intelligence, Scientific Content Generation, Literature Monitoring, and Safety Insights. The platform features include the Instant Insights Engine, Scientific Sentiment™, Intelligent Medical Themes™, and the Scientific Data Pool. Sorcero acquired Axiom Health in 2025 to expand into medical devices.

Product and service1 record
1Sorcero Intelligence Platform
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierMajorTypeTechnology or Integration
Description

Sorcero is hosted on Google Cloud Platform (carbon-neutral hosting) and serves as a Google Cloud partner, having been named Google Cloud's Partner of the Year for Healthcare & Life Sciences. The partnership includes co-authoring a whitepaper on Responsible AI for Life Sciences with Google and USDM Life Sciences. Available via Google Cloud Marketplace.

Strategic tierCoreTypeTechnology or Integration
Description

Snowflake is listed as a technology partner with a growing ecosystem relationship. Sorcero integrates with customer Snowflake data stores as part of its enterprise data integration capabilities.

Strategic tierCoreTypeTechnology or Integration
Description

Databricks is listed as a technology partner within Sorcero's growing ecosystem. Sorcero integrates with customer Databricks data stores for enterprise data integration.

Strategic tierGrowingTypeTechnology or Integration
Description

Komodo Health is listed as part of Sorcero's growing ecosystem of data and technology partners.

Strategic tierGrowingTypeTechnology or Integration
Description

The Lockwood Group is listed as part of Sorcero's growing ecosystem of data and technology partners, serving medical communications needs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sorcero partnered with USDM Life Sciences and Google to co-author 'A Comprehensive Guide to Responsible AI for Life Sciences' whitepaper. USDM provides expertise in life sciences AI compliance and validation frameworks, shaping Sorcero's approach to regulatory-grade AI deployment.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Sorcero partnered with MAPS (Medical Affairs Professional Society) to co-author the 'Medical Insights Transformation in the Age of AI' whitepaper, sponsors MAPS Americas 2026 conference (Booth #126, Field Medical Masterclass), and hosts joint webinars featuring industry leaders from pharma and biotech companies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lumanity collaborated with Sorcero and UCB on a published study demonstrating that bespoke AI tooling significantly reduces time and effort for professional medical writers developing Plain Language Summary abstracts. Research was published in JAMIA Open in April 2025.

Strategic tierSignificantTypeChannel Partner/ Reseller/ Distributor
Description

Sorcero is available via the NIH Carahsoft STRIDES Initiative on Google Cloud, simplifying procurement for government and academic institutions. This partnership enables public sector and academic buyers to purchase Sorcero through established government contracting vehicles.

Strategic tierGrowingTypeStrategic or Co-development Partner
Description

MSL Mastery (co-founded by Patrina Pellett, Ph.D. and Sarah Snyder, PharmD) co-hosted a Sorcero-MAPS webinar on AI reshaping MSL-HCP engagement. Patrina developed an automated 'email digest agent' tool featured in the webinar discussion.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers21 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sorcero

Life Sciences AI Intelligence Platformsorcero.com

Sorcero is a Washington, D.C.-based AI platform that delivers medically-tuned Agentic AI and data intelligence to global pharmaceutical, biotech, and medical device companies. It unifies 250M+ scientific publications and structured data into traceable insights for medical affairs, scientific communications, pharmacovigilance, and field medical workflows.

What Sorcero does

Sorcero, Inc. is a Washington, D.C.-based AI and data intelligence company founded in 2018 that builds a medically-tuned Agentic AI platform for the life sciences industry. The platform combines natural language processing with 1,000+ domain-specific biomedical ontologies to unify structured and unstructured data — including a Scientific Data Pool of 250M+ publications and 3.5M congress abstracts from 4,300+ global conferences — and produces traceable, evidence-grounded insights for medical affairs, scientific communications, pharmacovigilance, and medical device teams. The product is sold across three suites — Sorcero Medical™, Sorcero SciComms™, and Sorcero Safety™ — with adjunct solutions such as Field Medical Excellence & Insights, Congress Intelligence, Publication Intelligence, and the Therapy Resonance Profile.

The company operates an enterprise SaaS model sold primarily through direct high-touch field sales to global pharmaceutical companies, paired with dedicated Insights Leads, Deployment Strategists, and implementation services. Distribution channels include direct enterprise contracting (via procurement portals Ariba, Coupa, Jaggaer), the Google Cloud Marketplace, and the NIH Carahsoft STRIDES Initiative for public-sector buyers, with a native Sorcero Capture App on iPad/iPhone supporting field MSL workflows. Sorcero has raised $59M across a 2021 Series A and a 2025 Series B led by NewSpring Growth, acquired Axiom Health in 2025 to extend into medical devices, and reports penetration of approximately 40% of the top 30 global pharmaceutical companies. Certifications include SOC 2 Type II, ISO 27001, GDPR, DPF, and B Corporation status, with regulatory-grade performance benchmarks (99.83% sensitivity, 96.1% accuracy) supported by peer-reviewed validation studies in journals including JAMIA Open.

Sorcero firmographics

Firmographics
Name
Sorcero
Legal name
Sorcero, Inc.
Website
https://sorcero.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Sorcero is a Washington, D.C.-based AI platform that delivers medically-tuned Agentic AI and data intelligence to global pharmaceutical, biotech, and medical device companies. It unifies 250M+ scientific publications and structured data into traceable insights for medical affairs, scientific communications, pharmacovigilance, and field medical workflows.
Ownership category
akta.pro rank

Sorcero industry classification

Industry
Product category
Life Sciences AI Intelligence Platform
NAICS
Software Publishers (5132)
akta.pro industry
PRIMARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Medical affairs AI
  • Pharmacovigilance software
  • Literature monitoring automation
  • Scientific content generation
  • Biomedical intelligence platform

Where Sorcero is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Sorcero business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscription: Sorcero operates as a SaaS platform sold to enterprise life sciences organizations on a subscription basis, with enterprise contracts typically involving multi-year terms, dedicated implementation services, and platform licensing fees. The company pairs its platform with high-touch services including Insights Leads and Deployment Strategists to drive organizational alignment and adoption.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS platform with tiered product suites (Medical, SciComms, Safety)

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Sorcero product offering

Product offering

Core offering

Sorcero builds and sells a medically-tuned Agentic AI platform for life sciences organizations that unifies structured and unstructured medical evidence from publications, congresses, CRM notes, and internal data into traceable, actionable insights. The platform is delivered through three product suites — Sorcero Medical™, Sorcero SciComms™, and Sorcero Safety™ — and is sold as an enterprise SaaS subscription with high-touch implementation services targeting global pharmaceutical, biotech, and medical device companies.

Product overview

Sorcero offers a unified AI intelligence platform for life sciences with three main product suites: Sorcero Medical™ (for medical affairs strategy and insights), Sorcero SciComms™ (for scientific content generation and publication intelligence), and Sorcero Safety™ (for pharmacovigilance and literature monitoring). The platform is powered by the Sorcero Intelligence Platform which unifies data from disparate sources and leverages medically-tuned Agentic AI. Key solutions include Medical Insights Management, Field Medical Excellence & Insights, Congress Intelligence, Publication Intelligence, Scientific Content Generation, Literature Monitoring, and Safety Insights. The platform features include the Instant Insights Engine, Scientific Sentiment™, Intelligent Medical Themes™, and the Scientific Data Pool. Sorcero acquired Axiom Health in 2025 to expand into medical devices.

Differentiator

Problem solved

Functional benefit

Brands

  • Sorcero Medical™: Transforms fragmented data into unified, actionable intelligence for medical affairs teams, shifting scientific exchange from manual to strategic.
  • Sorcero SciComms™
  • Sorcero Safety™
  • Sorcero Intelligence Platform™
  • Sorcero Capture App™

Products and services

  • Sorcero Intelligence Platform

Quantifiable outcome

  • 72% reduction in medical data analysis time
  • +11 more outcomes

Companies that use Sorcero

Customer profile

Named customers21 records

Segments6 records

Ideal customer profiles5 records

Sorcero technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability10 records

Feature11 records

Sorcero partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered major, core, growing and significant.

  • Google CloudmajorTechnology or IntegrationSorcero is hosted on Google Cloud Platform (carbon-neutral hosting) and serves as a Google Cloud partner, having been named Google Cloud's Partner of the Year for Healthcare & Life Sciences. The partnership includes co-authoring a whitepaper on Responsible AI for Life Sciences with Google and USDM Life Sciences. Available via Google Cloud Marketplace.
  • SnowflakecoreTechnology or IntegrationSnowflake is listed as a technology partner with a growing ecosystem relationship. Sorcero integrates with customer Snowflake data stores as part of its enterprise data integration capabilities.
  • DatabrickscoreTechnology or IntegrationDatabricks is listed as a technology partner within Sorcero's growing ecosystem. Sorcero integrates with customer Databricks data stores for enterprise data integration.
  • Komodo HealthgrowingTechnology or IntegrationKomodo Health is listed as part of Sorcero's growing ecosystem of data and technology partners.
  • The Lockwood GroupgrowingTechnology or IntegrationThe Lockwood Group is listed as part of Sorcero's growing ecosystem of data and technology partners, serving medical communications needs.
  • USDM Life SciencescoreStrategic or Co-development PartnerSorcero partnered with USDM Life Sciences and Google to co-author 'A Comprehensive Guide to Responsible AI for Life Sciences' whitepaper. USDM provides expertise in life sciences AI compliance and validation frameworks, shaping Sorcero's approach to regulatory-grade AI deployment.
  • Medical Affairs Professional Society (MAPS)majorStrategic or Co-development PartnerSorcero partnered with MAPS (Medical Affairs Professional Society) to co-author the 'Medical Insights Transformation in the Age of AI' whitepaper, sponsors MAPS Americas 2026 conference (Booth #126, Field Medical Masterclass), and hosts joint webinars featuring industry leaders from pharma and biotech companies.
  • LumanitycoreStrategic or Co-development PartnerLumanity collaborated with Sorcero and UCB on a published study demonstrating that bespoke AI tooling significantly reduces time and effort for professional medical writers developing Plain Language Summary abstracts. Research was published in JAMIA Open in April 2025.
  • NIH / CarahsoftsignificantChannel Partner/ Reseller/ DistributorSorcero is available via the NIH Carahsoft STRIDES Initiative on Google Cloud, simplifying procurement for government and academic institutions. This partnership enables public sector and academic buyers to purchase Sorcero through established government contracting vehicles.
  • MSL MasterygrowingStrategic or Co-development PartnerMSL Mastery (co-founded by Patrina Pellett, Ph.D. and Sarah Snyder, PharmD) co-hosted a Sorcero-MAPS webinar on AI reshaping MSL-HCP engagement. Patrina developed an automated 'email digest agent' tool featured in the webinar discussion.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Sorcero competitors and assessment

Company assessment

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

Sorcero social profiles

Digital presence

Sorcero compliance and trust

Trust signal

Compliance5 records

Sorcero financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sorcero leadership team

Management profile

Number of profiles

Profiles10 records

Sorcero subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Sorcero funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sorcero M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sorcero

What does Sorcero do?

Sorcero builds and sells a medically-tuned Agentic AI platform for life sciences organizations that unifies structured and unstructured medical evidence from publications, congresses, CRM notes, and internal data into traceable, actionable insights. The platform is delivered through three product suites — Sorcero Medical™, Sorcero SciComms™, and Sorcero Safety™ — and is sold as an enterprise SaaS subscription with high-touch implementation services targeting global pharmaceutical, biotech, and medical device companies.

Is Sorcero a public or private company?

Sorcero is a private company. It is classified as venture growth investor backed and is currently operating.

When was Sorcero founded?

Sorcero was founded in 2018. It employs 51 to 100 people.

Where is Sorcero based?

Sorcero is headquartered in Washington, United States, in the North America region.

How does Sorcero make money?

One revenue line is on record: saaS Platform Subscription.

Does Sorcero have an API?

No public API is recorded for Sorcero.

What industry is Sorcero in?

Sorcero's product category is Life Sciences AI Intelligence Platform. Its primary akta.pro industry code is HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence, with a secondary code of HLAGAJAK, Pharmacovigilance & Drug Safety Software. Its NAICS code is 5132.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSorcero's Fall 2026 Release Gives Every Function Within Medical Affairs a Purpose-Built AI Solution on One Governed AI and Data PlatformSorcero announced its Fall 2026 release, expanding Sorcero Medical into a single governed platform for medical affairs teams. The release adds Medical Strategy for stakeholder alignment scoring, Sorcero Wizard conversational AI, and an AI Help Center, with compliance certifications including SOC II Type 2 and GxP.The Times of IndiaET WLF 2026: AI growth needs governance, financial discipline to stay sustainableAI executives at an ET panel discussion on the World Leaders Forum 2026 said governance, financial discipline and safety are essential as AI scales. Krishna Rangasayee of SiMa.ai said about 87% of AI usage generates no revenue or profit, while Dipanwita Das of Sorcero and Sudip Roy of Adaption stressed unit economics and reskilling.Third NewsSorcero Achieves Recognition as One of America's Fastest-Growing Companies for 2026Sorcero, an AI platform serving the life sciences sector, was named on the 2026 Inc. 5000 list of America's fastest-growing private companies, securing the 923rd position for the second consecutive year. The company focuses on improving medical evidence access and efficiency in scientific content generation, expanding its solutions within the healthcare industry.PR NewswireSorcero Named to the 2026 Inc. 5000 List of Fastest-Growing Private Companies in AmericaSorcero, an AI-powered life sciences platform, was named to the 2026 Inc. 5000 list, ranking No. 923 for a second consecutive year. The company's medically tuned AI cuts scientific data analysis time by over 72% and is over 96% accurate. It continues to expand solutions like Therapy Resonance Profile and Scientific Content Generation.PR NewswireNew Sorcero Therapy Resonance Profile Gives Medical Affairs a Real-Time Understanding of How Its Science is Landing in the MarketSorcero launched the Therapy Resonance Profile (TRP) in its Sorcero Medical™ product suite, providing medical affairs teams with continuous, evidence-based monitoring of how their scientific narrative resonates across the market. The product replaces lagging quarterly reports with real-time intelligence powered by the Strategic Alignment Framework, addressing the gap between evidence and clinical adoption that currently delays new science by 17 years. The launch targets life sciences companies commercializing precision therapies, with the company citing that $300 billion in revenue goes off patent by 2030.AijournSorcero CEO Dipanwita Das Among Only 3 Founders in Life Sciences AI Recognized on 2026 100 Women in AISorcero CEO Dipanwita Das was named to the 2026 100 Women in AI list, becoming one of only three female founders in life sciences AI recognized on the list, joining innovators from companies including Anthropic, OpenAI, NVIDIA, and Microsoft. The recognition follows Sorcero's strong 2025 performance, which included a $42.5M Series B led by NewSpring Capital and being named Google Cloud's Partner of the Year for Healthcare & Life Sciences. Sorcero's medically-tuned AI platform, which delivers 96.1% clinical accuracy and serves 40% of the top 30 global pharma companies, was highlighted as part of the recognition.PR NewswireSorcero CEO Dipanwita Das Among Only 3 Founders in Life Sciences AI Recognized on 2026 100 Women in AISorcero CEO Dipanwita Das was named to the 2026 100 Women in AI list, becoming one of only three female founders recognized for shaping AI adoption in life sciences. Sorcero's medically-tuned AI platform powers 40% of the top 30 global pharmaceutical companies, delivering 96.1% clinical accuracy and reducing scientific data analysis time by over 72%. The recognition follows Sorcero's $42.5M Series B funding round led by NewSpring Capital in 2025.YahooSorcero CEO Dipanwita Das Among Only 3 Founders in Life Sciences AI Recognized on 2026 100 Women in AISorcero CEO Dipanwita Das was named to the 2026 100 Women in AI list, becoming one of only three female founders recognized for shaping AI adoption in life sciences. Sorcero's AI platform delivers 96.1% clinical accuracy, serves 40% of the top 30 global pharma companies, and cut scientific data analysis time by over 72% in 2025. The recognition follows Sorcero's $42.5M Series B funding round and industry accolades including Google Cloud Partner of the Year for Healthcare & Life Sciences.PR NewswireSorcero Introduces Field Medical Excellence & Insights and Congress Intelligence Solutions to Accelerate Evidence-based Medical Affairs StrategiesSorcero announced two new AI-powered solutions for medical affairs teams: Field Medical Excellence & Insights with a new iPad Capture App, and Congress Intelligence with scientific abstract data integration. The solutions unify fragmented data sources from CRM notes, advisory board transcripts, and conference abstracts, cutting weekly reporting time by over 72% and reducing ad hoc data analysis time by up to 90%. The Congress Intelligence platform provides searchable access to 3.5 million abstracts from over 4,300 global conferences and generates AI synthesis immediately after events, eliminating the typical 60+ day wait for manual reports.